Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF
How to Cite
OrthoEvidence. Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF. ACE Report. 2020;9(2):12. Available from: https://myorthoevidene.com/AceReport/Report/12145
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip FracturesJ Bone Joint Surg Am.2020
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Hip fractures are one of the leading causes of disability worldwide, and continue to grow in numbers given the aging global population. When hip fractures are repaired with open reduction, internal fixation, there is concern about the bone quality and healing potential in this population. Thus, numerous different therapies have been investigated recently in an effort to promote bone healing in thi...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE